Xenon Pharmaceuticals Inc
(NAS:XENE)
$
40.76
2.12 (5.49%)
Market Cap: 3.09 Bil
Enterprise Value: 2.38 Bil
PE Ratio: 0
PB Ratio: 3.65
GF Score: 49/100 - Xenon Pharmaceuticals Inc Corporate Update TranscriptNov 27, 2023
- Q3 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023$32.15 (+1.13%)Earnings
- Xenon Pharmaceuticals Inc XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs TranscriptSep 19, 2023
- Q2 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2023$35.45 (+0.28%)Earnings
- Xenon Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Xenon Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2023
- Xenon Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Xenon Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023$43.54 (+2.45%)Earnings
- Xenon Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023$40.35 (+2.26%)Earnings
- Xenon Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Xenon Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022$35.4 (+1.81%)Earnings
- Q2 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022$39.35 (-0.76%)Earnings
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2022
- Q1 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022$28.57 (+12.30%)Earnings
- Xenon Pharmaceuticals Inc at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 03, 2022
- Xenon Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2022
- Q4 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022$31.76 (+0.19%)Earnings
- Xenon Pharmaceuticals Inc X-TOLE Results Update AES 2021 Call TranscriptDec 03, 2021
- Q3 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2021$33.79 (-4.14%)Earnings
- Xenon Pharmaceuticals Inc Positive Topline Results from Phase 2b 'X-TOLE' Clinical Trial of XEN1101 Call TranscriptOct 04, 2021
- Q2 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2021$18.68 (+11.19%)Earnings
- Xenon Pharmaceuticals Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Xenon Pharmaceuticals Inc Discussion of XEN1101 and the Focal Epilepsy Landscape TranscriptJul 12, 2021
- Q1 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2021$17.93 (-1.27%)Earnings
- Full Year 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2021$17.92 (-4.07%)Earnings
- Q3 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$11.85 (+5.52%)Earnings
- Q2 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$11.3 (-1.22%)Earnings
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2020
- Q1 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 21, 2020$13.87 (-2.94%)Earnings
- Q4 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2020$12.12 (-14.53%)Earnings
- Xenon Pharmaceuticals Inc. - Special Call TranscriptDec 02, 2019
- Q3 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019$9.15 (+1.44%)Earnings
- Q2 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$9.18 (+2.80%)Earnings
- Q1 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019$9.5 (-2.46%)Earnings
- Full Year 2018 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 06, 2019$8.78 (+1.27%)Earnings
Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript
Mar 28, 2023 / 05:00PM GMT
Release Date Price:
$34.62
(+0.52%)
Paul Matteis
Stifel Financial Corp. - Analyst
Great. Good afternoon, everybody. It's my pleasure to be with Ian Mortimer, President and CEO of Xenon. Ian, it's always great to see you. We've done a number of panels together even in the past six months, so sorry to have to deal with me again. And Sherry Aulin, CFO. Sorry, Sherry, you disappeared for a second off of my screen, so I didn't know if [you're in this meeting] or not.
Before we start, Ian, did you run this morning? And if so, how far?
Ian Mortimer
Xenon Pharmaceuticals, Inc. - President and CEO
I did run this morning. I did 10 miles, yeah.
Paul Matteis
Stifel Financial Corp. - Analyst
Okay. Easy day?
Ian Mortimer
Xenon Pharmaceuticals, Inc. - President and CEO
Easy day.
Questions & Answers
Paul Matteis
Stifel Financial Corp. - Analyst
All right. That's awesome. Cool, okay. With that, do you want to just give us an update of the 1101 pivotal
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)